Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Crispr Therapeutics Ag
(NQ:
CRSP
)
47.88
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
47.88
Bid (Size)
47.88 (4)
Ask (Size)
47.95 (6)
Prev. Close
47.88
Today's Range
47.88 - 47.88
52wk Range
43.42 - 91.10
Shares Outstanding
78,935,098
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Down 47% Since March, Is CRISPR Therapeutics Stock a Buy on the Dip?
November 24, 2024
Via
The Motley Fool
3 Monster Stocks in the Making
November 23, 2024
Via
The Motley Fool
Performance
YTD
-27.52%
-27.52%
1 Month
+1.10%
+1.10%
3 Month
-2.62%
-2.62%
6 Month
-12.69%
-12.69%
1 Year
-33.14%
-33.14%
More News
Read More
Deciphering Disruption: Inside Cathie Wood's Latest Plays
November 16, 2024
Via
MarketBeat
Topics
Artificial Intelligence
ETFs
Exposures
Artificial Intelligence
2 Top Biotech Stocks to Buy Now and Hold For 5 Years or More
November 16, 2024
Via
The Motley Fool
Where Will CRISPR Therapeutics Be in 3 Years?
November 15, 2024
Via
The Motley Fool
3 Unstoppable Growth Stocks I'm Loading $25,000 Each Into by 2029
November 13, 2024
Via
The Motley Fool
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
November 08, 2024
Via
The Motley Fool
Smaller Cap Biotechs Are In Season: How Are We Doing?
November 07, 2024
Via
Talk Markets
3 Companies Building Tomorrow's Game-Changing Technologies
November 05, 2024
Via
The Motley Fool
Thinking of Buying CRISPR Therapeutics Stock? Watch These 2 Key Numbers
November 02, 2024
Via
The Motley Fool
Cathie Wood's Ark Innovation, Genomic ETFs Celebrate 10 Years: How Annual Returns Stack Up Against S&P 500
October 31, 2024
Via
Benzinga
Topics
ETFs
Stocks
Exposures
US Equities
12 High-Growth Stocks That Could Deliver Parabolic Returns
October 28, 2024
Via
The Motley Fool
The Ultimate Biotech Stock to Buy With $50 Right Now
October 26, 2024
Via
The Motley Fool
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
October 22, 2024
Via
The Motley Fool
Why We Buy Stocks
October 21, 2024
Via
The Motley Fool
3 Bargain Stocks to Buy in a Market That's Priced for Perfection
October 19, 2024
Via
The Motley Fool
Why I Keep Buying These 14 Incredible Growth Stocks
October 16, 2024
Via
The Motley Fool
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Is CRISPR Therapeutics Stock a Buy?
October 13, 2024
Via
The Motley Fool
2 Biotech Stocks That Are Screaming Buys This Month
October 12, 2024
Via
The Motley Fool
This Healthcare Growth Stock Could Be a Steal of a Deal Right Now
October 05, 2024
Via
The Motley Fool
These 2 Healthcare Stocks With Big Catalysts on the Horizon Can Make You Richer
October 02, 2024
Via
The Motley Fool
Pfizer Tanked A $5.4 Billion Takeover. Why Crispr, Agios, Beam Could Benefit.
September 26, 2024
Via
Investor's Business Daily
3 Dirt Cheap Stocks to Buy Right Now
September 21, 2024
Via
The Motley Fool
Down 21% This Year, Is CRISPR Therapeutics Stock Still a Buy?
September 19, 2024
Via
The Motley Fool
1 Biotech Stock Down 62% to Buy and Hold
September 12, 2024
Via
The Motley Fool
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
